VUB and VIB launch new Bio Incubator Brussels on VUB campus

VUB and VIB launch new Bio Incubator Brussels on VUB campus

Catalyst for collaboration and biotechnological innovation

December 5, 2024

ExeVir Announces Michael Garrett as New Chief Executive Officer

ExeVir Announces Michael Garrett as New Chief Executive Officer

Company developing antibody therapeutics against emerging viral threats

November 18, 2024

Zymofix secures €2 million to scale microbial solutions for sustainable agriculture and beyond

Zymofix secures €2 million to scale microbial solutions for sustainable agriculture and beyond

• Additional financing to advance proprietary fermentation technology • Looking to expand the team to support its rapid growth • Rebranded from N-Fix to Zymofix – learn more at Zymofix.com

November 12, 2024

European Soy Industry Gathered in Ghent, Belgium during most Northern Soy Field Event

European Soy Industry Gathered in Ghent, Belgium during most Northern Soy Field Event

Protealis Hosted First Soy Field Day Event in Belgium to Highlight Innovations in Northern European Soy Cultivation

September 12, 2024

MRM Health, a VIB spin-off company, appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors

MRM Health, a VIB spin-off company, appoints Grégoire Franoux as Chief Business Officer and Adds Ron Robison to its Board of Directors

Ghent, Belgium, September 10, 2024 – MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today announced the appointment of Grégoire Franoux, M.B.A., to the newly created role of Chief Business Officer. Concurrently, the company has strengthened its Board of Directors with the appointment of industry veteran Ron Robison, M.D.

September 10, 2024

Contact us

Lies Vanneste

Lies Vanneste

Investor Relations Manager, VIB

Get updates in your mailbox

By clicking "Subscribe" I confirm I have read and agree to the Privacy Policy.

About VIB

VIB is a leading life sciences research institute based in Belgium, renowned for its work in medical sciences, plant biology, microbiology, artificial intelligence and biotechnology. VIB's mission is to push the boundaries of scientific discovery, transform it into disruptive biotech innovations and support the growth of the life sciences ecosystem in Flanders (Belgium). VIB is a partnership with Ghent University, Hasselt University, KU Leuven, University of Antwerp, and Vrije Universiteit Brussel.

VIB drives the translation of research discoveries into innovative products and technologies for patients, consumers and society. It does so by launching new spin-offs, licensing intellectual property to companies, engaging in dynamic partnerships and fostering talent development. VIB has created 39 spin-offs in the healthcare and agrifood sectors, attracting over €1.8 billion in equity investment and has partnered intensely with industry, generating over €350 million in income. VIB’s research has led to dozens of innovative products brought to market for medical, agriculture, and food applications, with many more in development. Seven of its spin-off companies have reached the clinical stage.

Learn more at www.vib.be.

Contact